AXA SA
XMUN:AXA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AXA SA
XMUN:AXA
|
FR |
|
B
|
Biomarin Pharmaceutical Inc
F:BM8
|
US |
|
D
|
DaVita Inc
F:TRL
|
US |
|
M
|
Macy's Inc
XMUN:FDO
|
US |
|
D
|
Deutsche Boerse AG
F:DB1
|
DE |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
DUS:BOY
|
ES |
|
P
|
Proto Labs Inc
XMUN:PRZ
|
US |
|
A
|
Aedifica NV
SWB:AOO
|
BE |
Wall St Price Targets
AXA Price Targets Summary
AXA SA
According to Wall Street analysts, the average 1-year price target for AXA is 47.66 EUR with a low forecast of 41.07 EUR and a high forecast of 54.11 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AXA's stock price target?
Price Target
47.66
EUR
According to Wall Street analysts, the average 1-year price target for AXA is 47.66 EUR with a low forecast of 41.07 EUR and a high forecast of 54.11 EUR.
What is the Revenue forecast for AXA SA?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 5 years is 10%.
What is the Net Income forecast for AXA SA?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 6 years is 3%.
